chr8-37965417-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_000025.3(ADRB3):​c.1053C>G​(p.Asp351Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000716 in 1,397,246 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

ADRB3
NM_000025.3 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.87

Publications

0 publications found
Variant links:
Genes affected
ADRB3 (HGNC:288): (adrenoceptor beta 3) The protein encoded by this gene belongs to the family of beta adrenergic receptors, which mediate catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor is located mainly in the adipose tissue and is involved in the regulation of lipolysis and thermogenesis. Obesity and bodyweight-related disorders are correlated with certain polymorphisms in three subtypes of beta-adrenoceptor, among them, the ADRB3 gene.[provided by RefSeq, Oct 2019]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.28254294).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADRB3NM_000025.3 linkc.1053C>G p.Asp351Glu missense_variant Exon 1 of 2 ENST00000345060.5 NP_000016.1 P13945A8KAG8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADRB3ENST00000345060.5 linkc.1053C>G p.Asp351Glu missense_variant Exon 1 of 2 1 NM_000025.3 ENSP00000343782.3 P13945
ENSG00000285880ENST00000647937.1 linkc.537C>G p.Asp179Glu missense_variant Exon 1 of 2 ENSP00000497740.1 A0A3B3IT50
ADRB3ENST00000520341.2 linkn.1181C>G non_coding_transcript_exon_variant Exon 1 of 1 6

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000668
AC:
1
AN:
149734
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000409
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
7.16e-7
AC:
1
AN:
1397246
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
689156
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31438
American (AMR)
AF:
0.0000281
AC:
1
AN:
35622
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35680
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78968
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48350
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5658
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1078480
Other (OTH)
AF:
0.00
AC:
0
AN:
57922
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 07, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1053C>G (p.D351E) alteration is located in exon 1 (coding exon 1) of the ADRB3 gene. This alteration results from a C to G substitution at nucleotide position 1053, causing the aspartic acid (D) at amino acid position 351 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Benign
0.11
.;T
Eigen
Benign
0.024
Eigen_PC
Benign
0.15
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.81
T;D
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.28
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.6
.;M
PhyloP100
2.9
PrimateAI
Pathogenic
0.80
T
PROVEAN
Benign
-1.3
.;N
REVEL
Benign
0.046
Sift
Benign
0.34
.;T
Sift4G
Benign
0.24
.;T
Polyphen
0.27
.;B
Vest4
0.21
MutPred
0.60
.;Loss of sheet (P = 0.0817);
MVP
0.73
MPC
1.6
ClinPred
0.65
D
GERP RS
4.7
Varity_R
0.20
gMVP
0.16
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1394272449; hg19: chr8-37822935; API